Investment Summary |
|
|---|---|
| Date | 2019-05-14 |
| Target | Catalyst OrthoScience |
| Sector | Medical Products |
| Investor(s) | River Cities Capital Funds |
| Deal Type | Venture |
| Advisor(s) | Dentons (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Venture Capital Firm |
|---|---|
| Founded | 1994 |
| PE ASSETS | 750M USD |
| Size | Middle-Market |
| Type | Sector Agnostic |
River Cities Capital Funds is a growth equity investment firm focused on healthcare services and information technology companies. River Cities seeks to invest $5 to $15 million in companies with at least $5 million in revenue. The Firm generally targets companies that pursue large, established markets with disruptive, “better, faster, cheaper” solutions. River Cities Capital Funds was established in 1994 and is headquartered in Cincinnati, Ohio.
| DEAL STATS | # |
|---|---|
| Overall | 14 of 20 |
| Sector (Medical Products) | 4 of 7 |
| Type (Venture) | 10 of 13 |
| State (Florida) | 2 of 3 |
| Country (United States) | 14 of 20 |
| Year (2019) | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-02-28 |
Liquibase
Austin, Texas, United States Liquibase is a provider in the database release automation segment of the more broadly defined DevOps market. Liquibase helps enterprises accelerate the software delivery process by automating required database updates. As enterprises continue to adopt an agile methodology and DevOps practices, there is a growing realization that the database needs to be considered as part of this innovation process. Liquibase was established in 2012 and is based in Austin, Texas. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-02-11 |
Q’Apel
Fremont, California, United States Q’Apel is a neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions. Q’Apel was founded in 2016 and is based in Fremont, California. |
Buy | - |
